(No ratings)
Dr. Nura El-Haj, MD is a pediatric oncologist in Worcester, MA specializing in pediatric hematology/oncology, general pediatrics and pediatric neuro-oncology. She graduated from Trinity College Dublin School of Medicine in 2014 and has 12 years of experience. Dr. Nura El-Haj, MD is affiliated with UMass Memorial Medical Center and UMass Memorial Health.
UMass Memorial Health
Anemia
Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.
An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.
Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.
Blood Transfusion
Blood transfusions typically treat those who experience a substantial loss of blood from an injury or surgical procedure, or those who suffer from conditions that alter the blood supply or blood components. For example, a blood transfusion may contribute additional red blood cells to someone with anemia, a condition where the body does not produce enough red blood cells. Other conditions may include:
When a patient has sufficient blood volume and lacks one or more components, a complete blood count (CBC) test can help determine if a patient requires a transfusion by measuring four blood components: red blood cells, white blood cells, platelets, and hemoglobin. If any of the patient's component counts is significantly below a standard range, the patient will likely need a blood transfusion. The complete blood count test uses a needle to extract a small amount of blood for testing.
Blood transfusion recipients should be tested for their blood type, which is one of four different types: type A, B, AB, or O. Patients with A, B, and O blood can only receive a blood donation matching their blood type or of O blood, which is known as the universal donor. Those with AB blood are considered "universal recipients"; they may receive A, B, AB, or O blood. Further complicating blood types is the presence or absence of the RhD antigen, adding a positive or negative modifier that should also be considered. Incompatible blood donations may cause transfusion sickness, such as a hemolytic reaction, where the body fights the donated red blood cells.
In certain emergency or trauma situations, medical teams often do not perform a complete blood count (CBC) test or blood type test. In those cases, patients are often given O negative blood, which is universally accepted. Some patients have their blood type on a medical card or bracelet, allowing emergency medical teams to issue compatible blood without testing.
Transfusions are performed by inserting a needle attached to an intravenous line (IV) into a vein in the body. This IV line is attached to a bag of blood that steadily dispenses blood into the patient's bloodstream. The type, volume, and components of donated blood depend on the patient's condition and needs. After the transfusion is complete, patients are generally permitted to resume normal activity, unless prohibited by a condition or injury. Some patients may experience bruising or soreness around the area that the needle was inserted.
At times, a second complete blood count test is performed to determine if the transfusion has brought patients' component counts to normal levels. Some patients may require multiple blood transfusions to reach a healthy blood volume and blood component count.
Once patients' blood volumes and components reach sufficient levels, they will generally begin to feel better. Patients of all ages, from newborn infants to elderly adults, can receive a blood transfusion.
Hemophilia
Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:
Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.
Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.
Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.
Dr. Nura El-Haj, MD graduated from Trinity College Dublin School of Medicine in 2014. She completed residency at Baystate Medical Center. She is certified by the Board Certification: Pediatrics - General Pediatrics and has a state license in Massachusetts.
Medical School: Trinity College Dublin School of Medicine (2014)
Residency: Baystate Medical Center
Board Certification: Board Certification: Pediatrics - General Pediatrics
Licensed In: Massachusetts
Dr. Nura El-Haj, MD is associated with these hospitals and organizations:
Dr. Nura El-Haj, MD does not have any reviews yet, be the first to leave a review of Dr. Nura El-Haj, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Nura El-Haj, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Amgen Inc. |
$110
$110 |
|---|---|
| Genentech USA, Inc. |
$80
HEMLIBRA $80 |
| Food and Beverage | $191 |
|---|
Dr. Nura El-Haj's areas of specialization are pediatric hematology/oncology, general pediatrics, and pediatric neuro-oncology. Areas of expertise for Dr. El-Haj include bleeding, cancer, and sickle cell disease. She attended Trinity College Dublin School of Medicine and subsequently trained at UMass Memorial Medical Center and Baystate Medical Center for residency. She is affiliated with UMass Memorial Medical Center.